Pressroom: Media Coverage

Showing 281 - 300 of 609 news items

2013

Debt May Influence Young Doctors' Career Plans

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach commented on a study that found that medical school debt may influence the type of medicine young doctors go on to practice.

January 7, 2013
Getting Pregnant after Cancer

Fertility expert Joanne Kelvin discussed how to safely become pregnant after receiving cancer treatment.

January 1, 2013

2012

Does the Doctor Know Best?

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach discussed an essay he wrote in The New York Times about cancer screening guidelines.

December 29, 2012
Is the Cure for Cancer Inside You?

Immunologist Jedd Wolchok and surgical oncologist Daniel Coit spoke about the pioneering research of Nobel Prize winner Ralph Steinman.

December 23, 2012
A Gut Check for Bad Genes

Surgical oncologist Sam Yoon spoke about a rare genetic mutation that increases the likelihood of developing gastric cancer and the prophylactic surgery some patients are opting to receive to reduce their chances of developing the disease.

December 23, 2012
Making an Argument for a Narrower Focus in Charitable Donations

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on the breast cancer research made possible by charitable donations.

December 21, 2012
Sloan Kettering Gets Final Steel Beam Set on Cancer Center Construction in Harrison

Victor Ribaudo, Executive Director of Memorial Sloan Kettering’s Regional Care Network, commented on the construction progress of Memorial Sloan Kettering’s newest regional center set to open in Harrison, New York, in 2015.

December 20, 2012
More Pressure to Justify Cost of Cancer Drugs versus Benefits

Medical oncologist Leonard Saltz commented on Memorial Sloan Kettering’s decision not to carry a new colorectal cancer drug due to its cost and the rising costs of cancer care.

December 13, 2012
The Cancer Bomb: How Nuclear Sludge Gave Birth to an Experimental Leukemia Drug

David Scheinberg, Chair of the Molecular Pharmacology and Chemistry Program, discussed his research on actinium and its cancer-fighting abilities.

December 11, 2012
In Girl's Last Hope, Altered Immune Cells Beat Leukemia

Cell researcher Michel Sadelain commented on an experimental treatment in which the body’s own immune cells are reprogrammed to target and attack leukemia.

December 10, 2012
Should Breast Cancer Patients Skip the Pre-Op MRI?

Surgical oncologist Monica Morrow discussed a study she led that looked at whether preoperative MRIs may do more harm than good for women facing breast cancer surgery.

December 7, 2012
Working to “Add to the Solution"

Memorial Sloan Kettering Board member David M. Rubenstein spoke about his $10 million contribution to establish a new pancreatic cancer research center at the hospital, and Department of Surgery Vice Chair Ronald DeMatteo commented on the need for progress against the deadly disease.

December 7, 2012
Drugmakers Nudged by FDA to Find Childhood Cancer Cures

Pediatric oncologist Richard O’Reilly spoke about the challenges of testing pediatric cancer drugs and getting new treatments approved.

December 4, 2012
Questions and Answers about Preventive Double Mastectomy

Surgical oncologist Tari King answered questions about preventive double mastectomies, and why some women choose to have the procedure.

November 28, 2012
More Women Choose Double Mastectomy, but Study Says Many Don't Need It

Surgical oncologist Monica Morrow discussed a study she co-authored that found that more than three-quarters of women who opt for double mastectomies are not getting any benefit because their risk of cancer developing in the healthy breast is no greater than in women without cancer.

NPR
November 28, 2012
All That Glitters: A Glimpse into the Future of Cancer Screening

Medical oncologist Larry Norton spoke about the need for more-advanced cancer screening tools.

November 27, 2012
Humans and Big Data: Who Is In Charge?

Medical oncologist Larry Norton joined statistician Patrick Wolfe and neurotechnologist Aldo Faisal to discuss the potential uses of data supermachines such as IBM's Watson in medicine.

November 24, 2012
With Routine Mammograms, Some Breast Cancers May Be Overtreated

Diagnostic radiologist Carol Lee discussed a study that analyzed 30 years of data on breast cancer incidence and suggested that as many as a third of cancers detected through routine mammograms may not be life threatening. Epidemiologist Colin Begg also commented on the study in Reuters and Nature, and Memorial Sloan Kettering’s Breast Disease Management Team authored a letter to the editor about the study that was published in the New York Times.

NPR
November 21, 2012
When Is Ejaculation “Premature,” and When Should a Penis Be Made Numb?

Urologist and Director of the Male Sexual and Reproductive Medicine Program John Mulhall discussed premature ejaculation and ways to treat it.

November 14, 2012
Sanofi Halves Price of Cancer Drug Zaltrap after Sloan Kettering Rejection

Just three weeks after medical oncologist Leonard Saltz, epidemiologist Peter Bach, and Physician-in-Chief Robert Wittes authored an opinion piece on Memorial Sloan Kettering’s decision not to carry a new colorectal cancer drug due to its cost, the pharmaceutical company said it would cut the price of the drug in half.

November 9, 2012